Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT03775954 · ClinicalTrials.gov registry record

Fetal Electrophysiologic Abnormalities in High-Risk Pregnancies Associated With Fetal Demise

A clinical trial of Congenital Heart Disease and High Risk Pregnancy, sponsored by Medical College of Wisconsin.

Recruiting
Registry status
30
Enrollment target
2
Study locations

NCT03775954: Recruiting study of Congenital Heart Disease and High Risk Pregnancy, sponsored by Medical College of Wisconsin.

NCT03775954 is a study of Congenital Heart Disease and High Risk Pregnancy that is actively recruiting participants, run by Medical College of Wisconsin. The registered enrollment target is 30 participants, below the 474-participant average among 63 other Congenital Heart Disease trials with a reported enrollment target (94% lower). The trial reports 2 study locations across 1 state. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT03775954, a study of Congenital Heart Disease and High Risk Pregnancy, is actively recruiting participants, sponsored by Medical College of Wisconsin.

RECRUITING
Registry status
30 participants
Enrollment target
2
Study locations

Study Summary

Each year world-wide, 2.5 million fetuses die unexpectedly in the last half of pregnancy, 25,000 in the United States, making fetal demise ten-times more common than Sudden Infant Death Syndrome. This study will apply a novel type of non-invasive monitoring, called fetal magnetocardiography (fMCG) used thus far to successfully evaluate fetal arrhythmias, in order to discover potential hidden electrophysiologic abnormalities that could lead to fetal demise in five high-risk pregnancy conditions associated with fetal demise.

Primary Outcome

To measure and compare the fMCG heart rate variability in five pregnancy conditions associated with fetal demise, to those of gestation matched normal fetuses.

Conditions Studied

Congenital Heart Disease High Risk Pregnancy Long QT Syndrome Gastroschisis Stillbirth Fetal Arrhythmia Twin Monochorionic Monoamniotic Placenta Fetal Hydrops Fetal Demise Intrauterine Fetal Death

Interventions

  • DIAGNOSTIC_TEST Fetal Magnetocardiogram and Neonatal Electrocardiogram
  • GENETIC Substudy only: Maternal/Infant Pharmacogenomic assessment postnatally

Study Locations (2)

Wisconsin

  • University of Wisconsin - Madison - Madison
  • Medical College of Wisconsin - Milwaukee

Trial Details

FieldValue
Enrollment Target 30 participants
Start Date 2018-07-01
Est. Completion 2028-11-30
Medical College of Wisconsin

447 total trials

What NCT03775954 shows while recruiting

NCT03775954 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 30 participants, a relatively small participant target, below the 474-participant average among 63 other Congenital Heart Disease trials with a reported enrollment target (94% lower).

The record links to 10 conditions, with Congenital Heart Disease appearing as the primary indexed condition, and to 2 interventions - of which Fetal Magnetocardiogram and Neonatal Electrocardiogram is the first listed.

NCT03775954 reports a single indexed study location in Wisconsin.

Frequently Asked Questions

What is clinical trial NCT03775954 about?

NCT03775954 is a clinical study titled "Fetal Electrophysiologic Abnormalities in High-Risk Pregnancies Associated With Fetal Demise". Each year world-wide, 2.5 million fetuses die unexpectedly in the last half of pregnancy, 25,000 in the United States, making fetal demise ten-times more common than Sudden Infant Death Syndrome. This study will apply a novel type of non-invasive monitoring, called fetal magnetocardiography (fMCG) u...

What is the current status of trial NCT03775954?

This trial is currently recruiting. The enrollment target is 30 participants. The study started on 2018-07-01. Estimated completion is 2028-11-30.

What conditions does trial NCT03775954 study?

This clinical trial studies the following conditions: Congenital Heart Disease, High Risk Pregnancy, Long QT Syndrome, Gastroschisis, Stillbirth.

What interventions are being tested in trial NCT03775954?

The interventions under investigation include: Fetal Magnetocardiogram and Neonatal Electrocardiogram (DIAGNOSTIC_TEST), Substudy only: Maternal/Infant Pharmacogenomic assessment postnatally (GENETIC).

Who is sponsoring clinical trial NCT03775954?

This trial is sponsored by Medical College of Wisconsin, which has 447 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT03775954 being conducted?

This trial has 2 study locations across Wisconsin. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Learn More About Clinical Trials

Similar trials for Congenital Heart Disease

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Where NCT03775954's enrollment target sits among peer trials

30 56th of 63 higher than 7 of 63 other Congenital Heart Disease trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other Congenital Heart Disease trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT00977977 · 30 participants · Phase 2

    Rituximab Plus Cyclosporine in Idiopathic Membranous Nephropathy

  • NCT01459107 · 30 participants · Phase 2

    Human Upper Extremity Allotransplantation

  • NCT01666080 · 30 participants · NA

    Second or Greater Allogeneic Hematopoietic Stem Cell Transplant Using Reduced Intensity Conditioning (RIC)

  • NCT01720836 · 30 participants · Phase 1

    Study of the Immune Response of MUC1 (Mucin1) Peptide Vaccine for Non-small Cell Lung Cancer

Similar registry start date

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

  • NCT07125183 · started 2026-12 · Phase 2

    Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma

  • NCT07292298 · started 2026-11 · Phase 2

    Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates

  • NCT04263285 · started 2026-10 · NA

    Treatment of Depression Post-SCI

More recruiting context for NCT03775954

Source: ClinicalTrials.gov NCT03775954, the US trial registry maintained by the National Library of Medicine. NCT03775954 (small enrollment · single site footprint · recruiting) retrieved and formatted by PlainTrial, see methodology.